Orion Nutra

VANCOUVER, BRITISH COLUMBIA

FCM Global’s Co-Source Colombia model complements Orion’s downstream product development focus, enabling outsourced lower-cost cultivation and extraction without compromising customization, consistency, or quality. FCM also has local alliances available to manufacture and distribute a range of Orion products in Colombia and across LATAM. FCM’s platform is designed to flexibly integrate to Orion’s business requirements.

FCM Global is building a solid production-focused company. As Colombia’s first fully licensed producer (August 2017) and exporter (September 2017) for non-psychoactive cannabis for medical and research purposes, FCM is also in the final stages of receiving its high-THC licenses (anticipated mid-Q4 2018 approval). FCM is well-positioned to produce and supply a wide range of CBD and THC extracts, isolates, seeds, and strains to support Orion and to distribute internationally.

Medic Oasis, Inc. is a Quebec-based company currently in Stage 5 of its Health Canada application process. Quebec is Orion’s Canadian production headquarters and the next step in building a global footprint. Medic Oasis, when licensed, is strategic to Orion as a 99% owned subsidiary for both expanding its presence in the Canadian cannabis sector, as well as to enable import/export of oil from Colombia (via FCM) to other parts of Canada, Europe, and wider international markets. Medic Oasis will be an instrumental part of Orion’s development efforts for certain strains, potent extracts, nutraceuticals, and pharmaceuticals which incorporate cannabis and cannabis-based medical science.

Orion Nutraceuticals will set a new standard within Cannabis Life Sciences by producing and developing innovative products with key strategic partners in the industry. These partnerships contribute to our competitive advantages, which include low production costs, industrial-scale, high-quality, and global distribution. In order for the cannabis industry to reach its full potential it must reliably supply consumers with a variety of high-quality, tested, consistent, and safe products.

As the CBD market continues to evolve and expand through increased awareness and advances in research, nutraceutical science is becoming heavily involved. Orion is helping open the door to a new range of CBD-based and CBD-infused products which offer potentially better solutions for pain management, reduced inflammation, faster recovery times, and the offsetting of brain injuries. Orion has an aggressive strategy, in partnership with leading research organizations, professional athletes, and sports leagues, to introduce and promote an innovative line of sports medicine therapies and related wellness products.

Orion Nutraceuticals

FCM Global’s Co-Source Colombia model complements Orion’s downstream product development focus, enabling outsourced lower-cost cultivation and extraction without compromising customization, consistency, or quality. FCM also has local alliances available to manufacture and distribute a range of Orion products in Colombia and across LATAM. FCM’s platform is designed to flexibly integrate to Orion’s business requirements.

FCM Global is building a solid production-focused company. As Colombia’s first fully licensed producer (August 2017) and exporter (September 2017) for non-psychoactive cannabis for medical and research purposes, FCM is also in the final stages of receiving its high-THC licenses (anticipated mid-Q4 2018 approval). FCM is well-positioned to produce and supply a wide range of CBD and THC extracts, isolates, seeds, and strains to support Orion and to distribute internationally.

Medic Oasis, Inc. is a Quebec-based company currently in Stage 5 of its Health Canada application process. Quebec is Orion’s Canadian production headquarters and the next step in building a global footprint. Medic Oasis, when licensed, is strategic to Orion as a 99% owned subsidiary for both expanding its presence in the Canadian cannabis sector, as well as to enable import/export of oil from Colombia (via FCM) to other parts of Canada, Europe, and wider international markets. Medic Oasis will be an instrumental part of Orion’s development efforts for certain strains, potent extracts, nutraceuticals, and pharmaceuticals which incorporate cannabis and cannabis-based medical science.

Orion Nutraceuticals will set a new standard within Cannabis Life Sciences by producing and developing innovative products with key strategic partners in the industry. These partnerships contribute to our competitive advantages, which include low production costs, industrial-scale, high-quality, and global distribution. In order for the cannabis industry to reach its full potential it must reliably supply consumers with a variety of high-quality, tested, consistent, and safe products.

As the CBD market continues to evolve and expand through increased awareness and advances in research, nutraceutical science is becoming heavily involved. Orion is helping open the door to a new range of CBD-based and CBD-infused products which offer potentially better solutions for pain management, reduced inflammation, faster recovery times, and the offsetting of brain injuries. Orion has an aggressive strategy, in partnership with leading research organizations, professional athletes, and sports leagues, to introduce and promote an innovative line of sports medicine therapies and related wellness products.